Piper Jaffray Broadens Medical Technology Research Expertise with Addition of Matt Miksic

  
    
  
  
    
      Piper Jaffray has hired Matt Miksic to broaden the investment research 
      team’s coverage of the medical technology 
      sector. As a senior research analyst, Miksic will provide coverage of 
      ophthalmology, orthopedics and diversified medical technology companies. 
      He will be based in the firm’s New York office.
    
    
      Miksic joins Piper Jaffray from Morgan Stanley where he was a senior 
      research analyst covering the medical technology and hospital supply 
      sectors. Prior to Morgan Stanley, he gained experience as a senior 
      manager in the business consulting division at Arthur Andersen and also 
      spent five years with a software start-up company. Miksic earned a 
      bachelor’s degree in computer science from 
      Rutgers University and a Master of Business Administration degree from 
      the Leonard N. Stern School of Business at New York University.
    
    
      “Matt’s addition to 
      the investment research team will allow us to continue providing quality 
      investment recommendations and independent research in the medical 
      technology sector,” said Steve Buell, head of 
      investment research at Piper Jaffray. “With 
      his proven track record, we are well-positioned for broadening our 
      expertise and building on our leading health care research franchise.”
    
    
      Miksic has provided primary coverage for several high-profile medical 
      technology companies, including Beckman Coulter, Biomet, Dade Behring, 
      Hospira, Integra LifeSciences, Kyphon, LifeCell, NuVasive, Respironics, 
      Stryker and Zimmer.
    
    
      About Piper Jaffray
    
    
      Piper Jaffray Companies is a leading, international middle-market 
      investment bank and institutional securities firm, serving the needs of 
      middle-market corporations, private equity groups, public entities, 
      nonprofit clients and institutional investors. Founded in 1895, Piper 
      Jaffray provides a comprehensive set of products and services, including 
      equity and debt capital markets products; public finance services; 
      mergers and acquisitions advisory services; high-yield and structured 
      products; institutional equity and fixed-income sales and trading; and 
      equity and high-yield research. With headquarters in Minneapolis, Piper 
      Jaffray has 25 offices across the United States and international 
      locations in London, Hong Kong, and Shanghai. Piper Jaffray & Co. is the 
      firm's principal operating subsidiary. (NYSE: PJC) (http://www.piperjaffray.com)
    
    
      Since 1895. Member SIPC and FINRA.
    
    
      © 2008 Piper Jaffray & Co., 800 Nicollet 
      Mall, Suite 800, Minneapolis, Minnesota 55402-7020